• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞培养基中的血清和生长因子——综述引言

Serum and growth factors in cell culture media--an introductory review.

作者信息

Griffiths J B

出版信息

Dev Biol Stand. 1987;66:155-60.

PMID:3582744
Abstract

Amongst this bewildering array of growth factors, serum replacements and serum-free media is there a system which works well for most cell types used in biotechnology? If so is there a short-cut for novices in the field to be able quickly to select the right formulation. I hope the following discussion will enable those with experience in this field to share that experience so that we can get an indication of which compound works for which cell under which conditions. Also the cost in both yield and monetary terms needs to be kept in perspective as one option is to produce these very expensive factors from genetically engineered bacteria. Discussion points should include the question of why so many medium formulations still include serum at 0.1 or 0.5% i.e. what does this small quantity of serum provide and does it mean that in fact we cannot have a completely protein-free media to achieve optimal growth? In which case, what is the minimal acceptable level? An adaptation procedure to low-serum media is accepted as essential but in fact the time-scale for this varies enormously from laboratory to laboratory and the question must be asked "is this based on quantitative or empirical investigation"? I hope the following panel discussion will answer these questions as the correct use of growth factors is of vital importance to the future development of cell product technology. It is probably true to say that with the correct blend of these compounds all cell types can be grown in culture as successfully as the ubiquitous fibroblast.

摘要

在这一系列令人眼花缭乱的生长因子、血清替代物和无血清培养基中,是否存在一种对生物技术中使用的大多数细胞类型都适用的体系呢?如果有,对于该领域的新手来说,有没有捷径能让他们迅速选出正确的配方呢?我希望以下讨论能让该领域有经验的人分享他们的经验,以便我们能了解哪种化合物在何种条件下对哪种细胞有效。此外,从产量和成本两方面来看,成本都需要综合考虑,因为一种选择是从基因工程细菌中生产这些非常昂贵的因子。讨论要点应包括为什么如此多的培养基配方仍含有0.1%或0.5%的血清,即这少量血清能提供什么,这是否意味着实际上我们无法拥有完全无蛋白的培养基来实现最佳生长?如果是这样,可接受的最低水平是多少?适应低血清培养基的程序被认为是必不可少的,但实际上从一个实验室到另一个实验室,这个时间跨度差异极大,而且必须要问“这是基于定量研究还是经验研究”?我希望接下来的小组讨论能回答这些问题,因为正确使用生长因子对细胞产品技术的未来发展至关重要。或许可以说,通过这些化合物的正确组合,所有细胞类型都能像无处不在的成纤维细胞一样在培养中成功生长。

相似文献

1
Serum and growth factors in cell culture media--an introductory review.细胞培养基中的血清和生长因子——综述引言
Dev Biol Stand. 1987;66:155-60.
2
Culture media for propagation of mammalian cells, viruses, and other biologicals.用于培养哺乳动物细胞、病毒及其他生物制品的培养基。
Adv Biotechnol Processes. 1985;5:1-30.
3
Interdependent regulation of epithelial cell replication by nutrients, hormones, growth factors, and cell density.营养物质、激素、生长因子和细胞密度对上皮细胞复制的相互依赖调节。
Fed Proc. 1984 Jan;43(1):116-20.
4
Upflow anaerobic sludge blanket reactor--a review.上流式厌氧污泥床反应器——综述
Indian J Environ Health. 2001 Apr;43(2):1-82.
5
Serum-free culture of rat keratinocytes.大鼠角质形成细胞的无血清培养
In Vitro Cell Dev Biol Anim. 1994 Aug;30A(8):496-503.
6
p202 levels are negatively regulated by serum growth factors.p202水平受到血清生长因子的负调控。
Cell Growth Differ. 2000 Sep;11(9):475-83.
7
Design, formulation, and optimization of media.培养基的设计、配方及优化
Bioprocess Technol. 1995;21:89-137.
8
Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.不同培养基和生长因子对胎盘血干细胞扩增的作用:一项体外和体内研究。
Bone Marrow Transplant. 2002 Mar;29(5):443-8. doi: 10.1038/sj.bmt.1703390.
9
Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture.从适应无血清悬浮培养的中国仓鼠卵巢细胞中稳定生产人生长激素拮抗剂。
Biotechnol Prog. 1999 May-Jun;15(3):336-46. doi: 10.1021/bp9900460.
10
Serum-free media for periosteal chondrogenesis in vitro.用于体外骨膜软骨生成的无血清培养基。
J Orthop Res. 2004 Jul;22(4):716-25. doi: 10.1016/j.orthres.2003.10.020.

引用本文的文献

1
Carbon Nanotube Uptake Changes the Biomechanical Properties of Human Lung Epithelial Cells in a Time-dependent Manner.碳纳米管的摄取以时间依赖性方式改变人肺上皮细胞的生物力学特性。
J Mater Chem B. 2015;3:3983-3992. doi: 10.1039/C5TB00179J.
2
Improvement of the culture stability of non-anchorage-dependent animal cells grown in serum-free media through immobilization.通过固定化提高无血清培养基中非锚定依赖性动物细胞的培养稳定性。
Cytotechnology. 1995 Jun;19(2):111-24. doi: 10.1007/BF00749766.
3
Hybridoma growth and productivity: effects of conditioned medium and of inoculum size.
杂交瘤细胞生长和生产力:条件培养基和接种量的影响。
Cytotechnology. 1999 Jan;29(1):1-10. doi: 10.1023/A:1008060802286.
4
Cell-based influenza vaccines: progress to date.基于细胞的流感疫苗:迄今的进展。
Drugs. 2008;68(11):1483-91. doi: 10.2165/00003495-200868110-00002.
5
New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.肺病基本机制的新观点。1. 肺纤维化中的肺损伤、炎症介质和成纤维细胞活化。
Thorax. 1992 Dec;47(12):1064-74. doi: 10.1136/thx.47.12.1064.